CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C29604 | BRD-K85722200 | BRD-K85722200 | -- | -- | -- | Details |
C29605 | BRD-K85724483 | BRD-K85724483 | -- | -- | -- | Details |
C29606 | BRD-K85727265 | BRD-K85727265 | -- | -- | -- | Details |
C29607 | BRD-K85732814 | BG-1028 | -- | -- | -- | Details |
C29608 | BRD-K85736239 | BRD-K85736239 | -- | -- | -- | Details |
C29609 | BRD-K85739307 | BRD-K85739307 | -- | -- | -- | Details |
C29610 | BRD-K85741537 | BRD-K85741537 | -- | -- | -- | Details |
C29611 | BRD-K85742570 | BRD-K85742570 | -- | -- | -- | Details |
C29612 | BRD-K85751432 | refametinib | MAP2K1; MAP2K2 | MEK inhibitor | -- | Details |
C29613 | BRD-K85751793 | BRD-K85751793 | -- | -- | -- | Details |
C29614 | BRD-K85756431 | SA-1922111 | -- | -- | -- | Details |
C29615 | BRD-K85763971 | BRD-K85763971 | -- | -- | -- | Details |
C29616 | BRD-K85767870 | BRD-K85767870 | -- | -- | adenosine-phosphate | Details |
C29617 | BRD-K85769686 | BRD-K85769686 | -- | -- | -- | Details |
C29618 | BRD-K85770991 | BRD-K85770991 | -- | -- | -- | Details |
C29619 | BRD-K85773425 | BRD-K85773425 | -- | -- | -- | Details |
C29620 | BRD-K85774994 | BRD-K85774994 | -- | -- | -- | Details |
C29621 | BRD-K85775326 | BRD-K85775326 | -- | -- | -- | Details |
C29622 | BRD-K85776843 | BRD-K85776843 | -- | -- | -- | Details |
C29623 | BRD-K85779012 | BRD-K85779012 | -- | -- | -- | Details |
C29624 | BRD-K85790491 | BRD-K85790491 | -- | -- | -- | Details |
C29625 | BRD-K85794150 | BRD-K85794150 | -- | -- | -- | Details |
C29626 | BRD-K85797809 | SA-1460110 | -- | -- | -- | Details |
C29627 | BRD-K85799948 | BRD-K85799948 | -- | -- | -- | Details |
C29628 | BRD-K85802361 | BRD-K85802361 | -- | -- | -- | Details |
C29629 | BRD-K85802892 | BRD-K85802892 | -- | -- | -- | Details |
C29630 | BRD-K85803608 | BRD-K85803608 | -- | -- | -- | Details |
C29631 | BRD-K85804197 | BRD-K85804197 | -- | -- | -- | Details |
C29632 | BRD-K85805864 | BRD-K85805864 | -- | -- | -- | Details |
C29633 | BRD-K85806228 | BRD-K85806228 | -- | -- | -- | Details |
C29634 | BRD-K85807048 | BRD-K85807048 | -- | -- | -- | Details |
C29635 | BRD-K85813125 | BRD-K85813125 | -- | -- | -- | Details |
C29636 | BRD-K85815049 | BRD-K85815049 | -- | -- | -- | Details |
C29637 | BRD-K85818861 | BRD-K85818861 | -- | -- | -- | Details |
C29638 | BRD-K85821470 | BRD-K85821470 | -- | -- | -- | Details |
C29639 | BRD-K85821758 | BRD-K85821758 | -- | -- | -- | Details |
C29640 | BRD-K85822033 | BRD-K85822033 | -- | -- | -- | Details |
C29641 | BRD-K85823016 | BRD-K85823016 | -- | -- | -- | Details |
C29642 | BRD-K85827194 | BRD-K85827194 | -- | -- | -- | Details |
C29643 | BRD-K85833139 | dehydroepiandrosterone | -- | -- | -- | Details |
C29644 | BRD-K85843964 | BRD-K85843964 | -- | -- | -- | Details |
C29645 | BRD-K85851814 | BRD-K85851814 | -- | -- | -- | Details |
C29646 | BRD-K85853281 | BRD-K85853281 | TOP2A | Topoisomerase inhibitor | -- | Details |
C29647 | BRD-K85853911 | KUC104542N | -- | -- | KUC-104542N | Details |
C29648 | BRD-K85859564 | n-nitrosodiethanolamine | -- | -- | -- | Details |
C29649 | BRD-K85861721 | BRD-K85861721 | -- | -- | -- | Details |
C29650 | BRD-K85862256 | BRD-K85862256 | -- | -- | -- | Details |
C29651 | BRD-K85865817 | BRD-K85865817 | -- | -- | -- | Details |
C29652 | BRD-K85871428 | SC-68376 | MAPK14 | P38 MAPK inhibitor | -- | Details |
C29653 | BRD-K85872723 | kynurenic-acid | -- | -- | -- | Details |
C29654 | BRD-K85873301 | BRD-K85873301 | -- | -- | -- | Details |
C29655 | BRD-K85879095 | BRD-K85879095 | -- | -- | -- | Details |
C29656 | BRD-K85883481 | prednisone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C29657 | BRD-K85885948 | BRD-K85885948 | -- | -- | -- | Details |
C29658 | BRD-K85886293 | BRD-K85886293 | -- | -- | -- | Details |
C29659 | BRD-K85886395 | BRD-K85886395 | -- | -- | -- | Details |
C29660 | BRD-K85887470 | BRD-K85887470 | -- | -- | -- | Details |
C29661 | BRD-K85888199 | BRD-K85888199 | -- | -- | -- | Details |
C29662 | BRD-K85891179 | BRD-K85891179 | -- | -- | -- | Details |
C29663 | BRD-K85901675 | BRD-K85901675 | -- | -- | -- | Details |
C29664 | BRD-K85903480 | glutamyldopamine | -- | -- | -- | Details |
C29665 | BRD-K85906476 | BRD-K85906476 | -- | -- | -- | Details |
C29666 | BRD-K85907501 | BRD-K85907501 | -- | -- | -- | Details |
C29667 | BRD-K85908443 | BRD-K85908443 | -- | -- | -- | Details |
C29668 | BRD-K85909950 | BRD-K85909950 | -- | -- | -- | Details |
C29669 | BRD-K85912419 | BRD-K85912419 | -- | -- | -- | Details |
C29670 | BRD-K85916563 | BRD-K85916563 | -- | -- | -- | Details |
C29671 | BRD-K85917058 | BRD-K85917058 | -- | -- | -- | Details |
C29672 | BRD-K85919350 | BRD-K85919350 | -- | -- | -- | Details |
C29673 | BRD-K85925969 | zalcitabine | -- | -- | -- | Details |
C29674 | BRD-K85930698 | BRD-K85930698 | -- | -- | -- | Details |
C29675 | BRD-K85932041 | BRD-K85932041 | -- | -- | -- | Details |
C29676 | BRD-K85935038 | BRD-K85935038 | -- | -- | -- | Details |
C29677 | BRD-K85937960 | BRD-K85937960 | -- | -- | -- | Details |
C29678 | BRD-K85941484 | BRD-K85941484 | -- | -- | -- | Details |
C29679 | BRD-K85943445 | BRD-K85943445 | -- | -- | -- | Details |
C29680 | BRD-K85946956 | BRD-K85946956 | -- | -- | -- | Details |
C29681 | BRD-K85950149 | BRD-K85950149 | -- | -- | -- | Details |
C29682 | BRD-K85951787 | BRD-K85951787 | -- | -- | -- | Details |
C29683 | BRD-K85955502 | BRD-K85955502 | -- | -- | -- | Details |
C29684 | BRD-K85957472 | BRD-K85957472 | -- | -- | -- | Details |
C29685 | BRD-K85965830 | BRD-K85965830 | -- | -- | -- | Details |
C29686 | BRD-K85967137 | BRD-K85967137 | -- | -- | -- | Details |
C29687 | BRD-K85972696 | BRD-K85972696 | -- | -- | -- | Details |
C29688 | BRD-K85976669 | BRD-K85976669 | -- | -- | -- | Details |
C29689 | BRD-K85977570 | BRD-K85977570 | -- | -- | -- | Details |
C29690 | BRD-K85977749 | BRD-K85977749 | -- | -- | -- | Details |
C29691 | BRD-K85979978 | BRD-K85979978 | -- | -- | -- | Details |
C29692 | BRD-K85981997 | BRD-K85981997 | -- | -- | -- | Details |
C29693 | BRD-K85985071 | ellipticine | TOP2A; TOP2B | Topoisomerase inhibitor | -- | Details |
C29694 | BRD-K85996308 | BRD-K85996308 | -- | -- | -- | Details |
C29695 | BRD-K86002795 | BRD-K86002795 | -- | -- | -- | Details |
C29696 | BRD-K86003836 | flubendazole | TUBB | Tubulin inhibitor | -- | Details |
C29697 | BRD-K86004174 | BRD-K86004174 | -- | -- | -- | Details |
C29698 | BRD-K86008496 | BRD-K86008496 | -- | -- | -- | Details |
C29699 | BRD-K86011921 | BRD-K86011921 | -- | -- | -- | Details |
C29700 | BRD-K86019347 | BRD-K86019347 | -- | -- | -- | Details |
C29701 | BRD-K86023266 | BRD-K86023266 | -- | -- | -- | Details |
C29702 | BRD-K86025005 | BRD-K86025005 | -- | -- | -- | Details |
C29703 | BRD-K86027709 | BRD-K86027709 | -- | -- | -- | Details |